Ang L, Guo L, Wang J, Huang J, et al. Oncolytic virotherapy armed with an engineered interfering lncRNA exhibits
antitumor activity by blocking the epithelial mesenchymal transition in
triple-negative breast cancer. Cancer Lett 2020 Mar 18. pii: S0304-3835(20)30131.
PMID: 32200038